Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06223165 · ClinicalTrials.gov registry record · NA
Optimizing the Floreciendo Sexual and Reproductive Health Workshop for Latina Teens and Female Caregivers: A Pilot
A NA study of Sexually Transmitted Infections and Sexual Risk Behavior, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 184
- Enrollment target
- 4
- Study locations
NCT06223165: Recruiting NA study of Sexually Transmitted Infections and Sexual Risk Behavior, sponsored by University of Illinois at Chicago.
NCT06223165 is a NA study of Sexually Transmitted Infections and Sexual Risk Behavior that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 184 participants, below the 890-participant average among 10 other Sexually Transmitted Infections trials with a reported enrollment target (79% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06223165, a NA study of Sexually Transmitted Infections and Sexual Risk Behavior, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
- 4
- Study locations
Study Summary
Floreciendo is a sexual and reproductive health workshop for Latina teens (ages 14-18 years) and their female caregivers (e.g., mothers, sisters, grandmothers). This study involves conducting a pilot optimization trial of Floreciendo using the multiphase optimization strategy (MOST) framework. The feasibility of using a 2 x 2 x 2 factorial trial design and the acceptability of the intervention components of Floreciendo will be examined. Effectiveness and implementation outcomes will be explored. This work will be conducted in partnership with community-based organizations in the Chicagoland area.
Primary Outcome
Proportion of conditions implemented according to the randomization schedule (benchmark is at least 90%) (primary). We will also measure the proportion of teen-caregiver dyads who complete all sessions specified per their condition (benchmark is at least 80%), and proportion of teen-caregiver dyads who complete baseline assessments (benchmark is at least 80%) and follow-up assessments (benchmark is at least 80%).
Conditions Studied
Interventions
- BEHAVIORAL Floreciendo (Foundations, Condoms & Contraception, Family Strengthening, and Gender & Relationships)
- BEHAVIORAL Floreciendo (Foundations, Condoms & Contraception, and Family Strengthening)
- BEHAVIORAL Floreciendo (Foundations, Condoms & Contraception, Gender & Relationships)
- BEHAVIORAL Floreciendo (Foundations, Family Strengthening, and Gender & Relationships)
- BEHAVIORAL Floreciendo (Foundations and Condoms & Contraception)
Study Locations (4)
Illinois
- Gads Hill Center - Chicago
- Expanded Mental Health Services of Chicago NFP - Chicago
- Centro Romero - Chicago
- Corazon Community Services - Cicero
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2024-03-09 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT06223165 shows while recruiting
NCT06223165 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 890-participant average among 10 other Sexually Transmitted Infections trials with a reported enrollment target (79% lower).
The record links to 3 conditions, with Sexually Transmitted Infections appearing as the primary indexed condition, and to 5 interventions - of which Floreciendo (Foundations, Condoms & Contraception, Family Strengthening, and Gender & Relationships) is the first listed.
NCT06223165 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06223165 about?
NCT06223165 is a clinical study titled "Optimizing the Floreciendo Sexual and Reproductive Health Workshop for Latina Teens and Female Caregivers: A Pilot". Floreciendo is a sexual and reproductive health workshop for Latina teens (ages 14-18 years) and their female caregivers (e.g., mothers, sisters, grandmothers). This study involves conducting a pilot optimization trial of Floreciendo using the multiphase optimization strategy (MOST) framework. The f...
What is the current status of trial NCT06223165?
This trial is currently recruiting. It is a NA study. The enrollment target is 184 participants. The study started on 2024-03-09. Estimated completion is 2026-08.
What conditions does trial NCT06223165 study?
This clinical trial studies the following conditions: Sexually Transmitted Infections, Sexual Risk Behavior, Unplanned Pregnancy.
What interventions are being tested in trial NCT06223165?
The interventions under investigation include: Floreciendo (Foundations, Condoms & Contraception, Family Strengthening, and Gender & Relationships) (BEHAVIORAL), Floreciendo (Foundations, Condoms & Contraception, and Family Strengthening) (BEHAVIORAL), Floreciendo (Foundations, Condoms & Contraception, Gender & Relationships) (BEHAVIORAL), Floreciendo (Foundations, Family Strengthening, and Gender & Relationships) (BEHAVIORAL), Floreciendo (Foundations and Condoms & Contraception) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06223165?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06223165 being conducted?
This trial has 4 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexually Transmitted Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06223165's enrollment target sits among peer trials
184 9th of 10 higher than 2 of 10 other Sexually Transmitted Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sexually Transmitted Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gathering Online for Dialogue and Discussion to Enhance Social Support
RECRUITING · NA
-
Evaluation of the SafeSpace App Intervention
RECRUITING · NA
-
Technology-based Training Tool for PHAT Life
COMPLETED · NA
-
HIV Prevention Program for African American Teen Males
COMPLETED · NA
-
Microfinance and Health Intervention Trial for Youth in Dar es Salaam, Tanzania
COMPLETED · NA
-
Connecting Resources for Urban Sexual Health
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI